JP5426156B2 - Defecation promoting composition - Google Patents
Defecation promoting composition Download PDFInfo
- Publication number
- JP5426156B2 JP5426156B2 JP2008330423A JP2008330423A JP5426156B2 JP 5426156 B2 JP5426156 B2 JP 5426156B2 JP 2008330423 A JP2008330423 A JP 2008330423A JP 2008330423 A JP2008330423 A JP 2008330423A JP 5426156 B2 JP5426156 B2 JP 5426156B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- defecation
- group
- compound represented
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 27
- 230000013872 defecation Effects 0.000 title claims description 25
- 230000001737 promoting effect Effects 0.000 title claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 43
- 239000003205 fragrance Substances 0.000 description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000000523 sample Substances 0.000 description 11
- 235000013305 food Nutrition 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- -1 specifically Chemical group 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- 210000003608 fece Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- DRTFPRNYUARGTQ-KTKRTIGZSA-N (z)-2,3-dibutylbut-2-enedioic acid Chemical compound CCCC\C(C(O)=O)=C(C(O)=O)/CCCC DRTFPRNYUARGTQ-KTKRTIGZSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 239000003377 acid catalyst Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- XZYRJVLKSRQAGD-UHFFFAOYSA-N bis(2-Ethylhexyl)phthalic acid Chemical compound CCCCC(CC)CC1=CC=C(C(O)=O)C(C(O)=O)=C1CC(CC)CCCC XZYRJVLKSRQAGD-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- PDVFSPNIEOYOQL-UHFFFAOYSA-N (4-methylphenyl)sulfonyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OS(=O)(=O)C1=CC=C(C)C=C1 PDVFSPNIEOYOQL-UHFFFAOYSA-N 0.000 description 3
- YEVWZGJURAGMOP-ZCXUNETKSA-N (z)-2,3-dioctylbut-2-enedioic acid Chemical compound CCCCCCCC\C(C(O)=O)=C(C(O)=O)/CCCCCCCC YEVWZGJURAGMOP-ZCXUNETKSA-N 0.000 description 3
- KGDLKOAYUABDIH-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl)benzene Chemical compound CCCCC(CC)CC1=CC=C(CC(CC)CCCC)C=C1 KGDLKOAYUABDIH-UHFFFAOYSA-N 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 3
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 3
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- NMRPBPVERJPACX-UHFFFAOYSA-N (3S)-octan-3-ol Natural products CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 description 2
- WNUSGTHPIUVPQN-ZCXUNETKSA-N (z)-2,3-bis(2-ethylhexyl)but-2-enedioic acid Chemical compound CCCCC(CC)C\C(C(O)=O)=C(C(O)=O)/CC(CC)CCCC WNUSGTHPIUVPQN-ZCXUNETKSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- WOFPPJOZXUTRAU-UHFFFAOYSA-N 2-Ethyl-1-hexanol Natural products CCCCC(O)CCC WOFPPJOZXUTRAU-UHFFFAOYSA-N 0.000 description 2
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 2
- 239000001738 pogostemon cablin oil Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Natural products OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 238000000585 Mann–Whitney U test Methods 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000000222 aromatherapy Methods 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- ROPXFXOUUANXRR-YPKPFQOOSA-N bis(2-ethylhexyl) (z)-but-2-enedioate Chemical compound CCCCC(CC)COC(=O)\C=C/C(=O)OCC(CC)CCCC ROPXFXOUUANXRR-YPKPFQOOSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- JBSLOWBPDRZSMB-FPLPWBNLSA-N dibutyl (z)-but-2-enedioate Chemical compound CCCCOC(=O)\C=C/C(=O)OCCCC JBSLOWBPDRZSMB-FPLPWBNLSA-N 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- TVWTZAGVNBPXHU-FOCLMDBBSA-N dioctyl (e)-but-2-enedioate Chemical compound CCCCCCCCOC(=O)\C=C\C(=O)OCCCCCCCC TVWTZAGVNBPXHU-FOCLMDBBSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229940100563 gas for inhalation Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 230000003880 negative regulation of appetite Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000004800 psychological effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000004037 social stress Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Description
本発明は排便促進用組成物に関する。より詳しくは、特定の化合物を含有する排便促進用組成物に関する。 The present invention relates to a defecation promoting composition. More specifically, the present invention relates to a defecation promoting composition containing a specific compound.
近年、食生活の欧米化に伴う食事の変化、慢性的な運動不足、社会的ストレスの増加等に伴い、便秘の症状に悩まされる人が増加している。便秘は女性や高齢者に多く認められ、その解消は大いに期待されるところである。便秘の主な解消方法としては、食生活の改善、軽い運動等による予防方法や改善方法の他、薬による治療方法が挙げられる。 In recent years, the number of people suffering from symptoms of constipation has increased with changes in diet, chronic lack of exercise, and increased social stress associated with the Westernization of eating habits. Constipation is common in women and the elderly, and its elimination is highly expected. The main methods for relieving constipation include a dietary improvement, a preventive method and an improved method by light exercise, and a therapeutic method using drugs.
一方、アロマ製剤に用いられる天然精油により、覚醒、睡眠、食欲増進、食欲抑制などの効果がもたらされるとのことから、アロマテラピーが注目を集めている。特許文献1では、パチュリー油等の特定の精油を含有する便意促進用の香料組成物が開示されている。また、特許文献2では、パチュリー油及び食物繊維を含有する排便促進用経口組成物が開示されている。
特許文献1及び2では、用いた精油が排便促進作用という生理的作用を有するものであることを報告しているが、精油そのものには「香り」による心理的作用に関連する効果も大きく認められることから、より優れた排便促進作用を有する機能性芳香剤が望まれる。 In Patent Documents 1 and 2, it is reported that the used essential oil has a physiological function of defecation promotion, but the essential oil itself also has a large effect related to the psychological action due to “fragrance”. Therefore, a functional fragrance having an excellent defecation promoting action is desired.
本発明の課題は、より優れた排便促進作用を有する排便促進用組成物を提供することにある。 An object of the present invention is to provide a defecation promoting composition having a more excellent defecation promoting action.
本発明者は、上記課題を解決すべく鋭意検討した結果、図書館のような古書がある場所では便意を催しやすくなるという生理現象に着目し、該生理現象を誘導する物質を特定することにより、下記の構造を有する化合物が排便促進作用に優れていることを見出し、本発明を完成するに至った。 As a result of intensive studies to solve the above problems, the present inventor has focused on a physiological phenomenon that facilitates convenience in places where there are old books such as libraries, and by specifying a substance that induces the physiological phenomenon, The inventors have found that a compound having the following structure is excellent in defecation promoting action, and have completed the present invention.
即ち、本発明は、後述の式(III)、式(IV)、式(VI)、及び式(VII)からなる群より選ばれる1種以上の化合物を含有してなる、排便促進用組成物、に関する。 That is, the present invention includes a composition for promoting defecation, comprising at least one compound selected from the group consisting of formula (III), formula (IV), formula (VI), and formula (VII) described later . , Regarding.
本発明の排便促進用組成物は、排便を促進することができるという優れた効果を奏する。 The composition for promoting defecation of the present invention has an excellent effect of being able to promote defecation.
本発明の排便促進用組成物は、式(I):
R1−X−R2 (I)
〔式中、R1及びR2はそれぞれ独立して、炭素数1〜8の、直鎖又は分岐鎖のアルキル基、Xは式(II):
The composition for promoting defecation of the present invention has the formula (I):
R 1 —X—R 2 (I)
[Wherein, R 1 and R 2 are each independently a linear or branched alkyl group having 1 to 8 carbon atoms, and X is a group represented by the formula (II):
(式中、Yはビニレン基もしくはフェニレン基である)
で表される官能基、又はフェニレン環である〕
で表される化合物を含有することに大きな特徴を有する。なお、本明細書において「排便促進用組成物」とは、食品のように摂取するのみならず、芳香をかぐだけでも、排便の促進作用を発揮できる組成物である。
(In the formula, Y is a vinylene group or a phenylene group)
Or a phenylene ring.
It has the big characteristic in containing the compound represented by these. In the present specification, the “defecation facilitating composition” is a composition capable of exerting the defecation promoting effect not only by ingesting like a food but also by smelling a fragrance.
式(I)におけるR1及びR2は、それぞれ独立して、炭素数1〜8の、直鎖又は分岐鎖のアルキル基であり、具体的には、メチル基、エチル基、プロピル基、ブチル基、ヘキシル基、オクチル基、イソプロピル基、2−エチルヘキシル基、2−イソプロパニルペンタニル基、2,2−ジイソプロパニル基等が例示される。なかでも、入手方法が容易であること等から、ブチル基、2−エチルヘキシル基、オクチル基が好ましく、R1及びR2のいずれもが、ブチル基、2−エチルヘキシル基、又はオクチル基であることがより好ましい。 R 1 and R 2 in the formula (I) are each independently a linear or branched alkyl group having 1 to 8 carbon atoms, specifically, methyl group, ethyl group, propyl group, butyl group Group, hexyl group, octyl group, isopropyl group, 2-ethylhexyl group, 2-isopropanylpentanyl group, 2,2-diisopropanyl group and the like are exemplified. Of these, a butyl group, a 2-ethylhexyl group, and an octyl group are preferred because of easy availability, and both R 1 and R 2 are a butyl group, a 2-ethylhexyl group, or an octyl group. Is more preferable.
式(I)で表される化合物の好適例としては、式(III): Preferable examples of the compound represented by the formula (I) include a compound represented by the formula (III):
で表される化合物(ジブチルマレイン酸)、式(IV): A compound represented by the formula (dibutylmaleic acid), formula (IV):
で表される化合物(ジオクチルマレイン酸)、式(V): A compound represented by the formula (dioctylmaleic acid), formula (V):
で表される化合物〔ビス(2−エチルヘキシル)フマル酸〕、式(VI): [Bis (2-ethylhexyl) fumaric acid] represented by formula (VI):
で表される化合物〔1,4−ビス(2−エチルヘキシル)ベンゼン〕、及び式(VII): [1,4-bis (2-ethylhexyl) benzene] represented by the formula (VII):
で表される化合物〔ビス(2−エチルヘキシル)フタル酸〕が挙げられる。 And a compound represented by the formula [bis (2-ethylhexyl) phthalic acid].
本発明の排便促進用組成物において、上記式(I)で表される化合物を単独で又は2種以上を適宜組合せて用いることができる。 In the composition for promoting defecation of the present invention, the compounds represented by the above formula (I) can be used alone or in combination of two or more.
式(I)で表される化合物は、公知化合物、又は公知化合物から容易に誘導される化合物である。また、式(I)で表される化合物は、基本骨格や置換基の種類等に応じて、種々の公知の合成方法により製造することができる。 The compound represented by the formula (I) is a known compound or a compound easily derived from a known compound. In addition, the compound represented by the formula (I) can be produced by various known synthesis methods depending on the basic skeleton, the type of substituent, and the like.
例えば、式(III)で表される化合物は、マレイン酸1重量部に対して6重量部のブタノールを加えて混合後、前記混合物の総重量に対して、5%重量の脱水触媒〔濃硫酸、燐酸、スルファミン酸、p−トルエンスルホン酸無水物、イオン交換樹脂(Lewatit S 100、強酸型)等〕を添加して加熱還流することにより、分子内脱水縮合が行なわれて得ることができる(収率40〜65%)。 For example, the compound represented by the formula (III) is prepared by adding 6 parts by weight of butanol to 1 part by weight of maleic acid, mixing, and then adding 5% by weight of a dehydration catalyst [concentrated sulfuric acid to the total weight of the mixture. , Phosphoric acid, sulfamic acid, p-toluenesulfonic acid anhydride, ion exchange resin (Lewatit S 100, strong acid type, etc.)] and heating to reflux can be carried out by intramolecular dehydration condensation ( Yield 40-65%).
本発明の排便促進用組成物には、本発明の効果を損なわない範囲で、上記式(I)で表される化合物以外に、該化合物と同じ用途に使用可能な他の成分、例えば公知の排便促進作用を有する精油や合成香料等(以下、公知の香料成分という)を配合してもよい。ただし、本発明の排便促進用組成物において、式(I)で表される化合物と公知の香料成分〔式(I)で表される化合物以外の香料成分〕の総量における式(I)で表される化合物の含有量は、好ましくは1重量%以上、より好ましくは10重量%以上、さらに好ましくは実質的に100重量%である。 In the composition for promoting defecation of the present invention, in addition to the compound represented by the above formula (I), other components that can be used for the same use as the compound, for example, known compounds, as long as the effects of the present invention are not impaired. You may mix | blend the essential oil, synthetic fragrance | flavor, etc. (henceforth a well-known fragrance | flavor component) which has a defecation promotion effect | action. However, in the composition for promoting defecation of the present invention, the composition represented by the formula (I) in the total amount of the compound represented by the formula (I) and a known fragrance component [a fragrance component other than the compound represented by the formula (I)]. The content of the compound to be formed is preferably 1% by weight or more, more preferably 10% by weight or more, and still more preferably substantially 100% by weight.
本発明の排便促進用組成物における式(I)で表される化合物の含有量は、該組成物の使用形態、期待される効果の程度、使用者の性別や年齢等によって一概には決定されず、通常0.1〜100重量%程度である。 The content of the compound represented by formula (I) in the composition for promoting defecation of the present invention is generally determined by the use form of the composition, the degree of expected effect, the sex and age of the user, etc. Usually, it is about 0.1 to 100% by weight.
本発明の組成物は、式(I)で表される化合物を含有するものであれば、特に限定はなく、使用形態に応じて、担体、基材又は添加物等の他の成分を含有していてもよい。 The composition of the present invention is not particularly limited as long as it contains the compound represented by the formula (I), and contains other components such as a carrier, a substrate or an additive depending on the form of use. It may be.
本発明の組成物は、式(I)で表される化合物が吸入され得る限り、その使用形態について特に限定はない。本発明の組成物の使用形態としては、芳香剤、吸入剤、食品、木工加工品等が挙げられるが、これらに限定されない。 As long as the compound represented by the formula (I) can be inhaled, the composition of the present invention is not particularly limited in its use form. Examples of usage forms of the composition of the present invention include, but are not limited to, fragrances, inhalants, foods, processed wood products and the like.
芳香剤としては、排便を促進する観点から、トイレ用芳香剤として用いることが好ましい。芳香剤の製品形態としては、固形状、半固形状(ゼリー状、ゲル状等)、液体状、エアゾール状等が例示されるが、特に限定はない。また、当該芳香剤は、式(I)で表される化合物を自然蒸散させることにより使用してもよく、ファンにより強制的に揮散させることにより使用してもよく、また該化合物を加熱により蒸散させてもよい。 The fragrance is preferably used as a toilet fragrance from the viewpoint of promoting defecation. Examples of the product form of the fragrance are solid, semi-solid (jelly, gel, etc.), liquid, aerosol and the like, but are not particularly limited. In addition, the fragrance may be used by spontaneously evaporating the compound represented by the formula (I), or may be used by forcibly evaporating with a fan, and the compound is evaporated by heating. You may let them.
芳香剤は、式(I)で表される化合物を含有する限り、従来の芳香剤に使用されている公知の基剤、担体、添加剤等の他の成分を含有することができ、適宜、常法により製造することができる。基材としては、例えば、水、エタノール、固体又は液体の陰イオン性、陽イオン性、非イオン性活性剤、高分子剤、油脂、グアーガム、キサンタンガム、アラビアガム、ジェランガム、カラギーナン、ゼラチン、寒天、非水溶性溶剤、ろう、ワセリン、ラノリンが挙げられる。 As long as the fragrance contains the compound represented by the formula (I), it can contain other components such as known bases, carriers, additives and the like used in conventional fragrances. It can be produced by a conventional method. Examples of the base material include water, ethanol, solid or liquid anionic, cationic, nonionic active agent, polymer agent, fat, guar gum, xanthan gum, gum arabic, gellan gum, carrageenan, gelatin, agar, Non-water-soluble solvents such as wax, petrolatum and lanolin can be mentioned.
芳香剤における式(I)で表される化合物の含有量は、0.1〜99.9重量%が好ましく、1〜90重量%がより好ましい。 The content of the compound represented by the formula (I) in the fragrance is preferably 0.1 to 99.9% by weight, more preferably 1 to 90% by weight.
吸入剤とは、式(I)で表される化合物を鼻付近で揮散又は鼻腔に適用させることにより該化合物を吸入させる製剤のことであり、その具体例としては点鼻薬、噴霧剤、吸入液、該化合物を担持させたマスク等が挙げられる。吸入剤は、式(I)で表される化合物を含有する限り、従来の吸入剤に使用されている公知の基剤、担体、添加剤等の他の成分を含有することができ、適宜、常法により製造することができる。また、吸入用の気体を使用する場合も従来の吸入剤に使用されている気体を使用することができる。 The inhalant is a preparation for inhaling the compound represented by the formula (I) by volatilization in the vicinity of the nose or application to the nasal cavity. Specific examples thereof include nasal drops, sprays, and inhalation solutions. And a mask carrying the compound. As long as the inhalant contains the compound represented by the formula (I), it can contain other components such as known bases, carriers, additives and the like used in conventional inhalants. It can be produced by a conventional method. Moreover, when using the gas for inhalation, the gas currently used for the conventional inhalant can be used.
吸入剤の投与量は、その投与方法、及び当該吸入剤の投与対象である患者の年齢、体重、症状によって適宜設定され一定ではない。また、投与は、所望の投与量範囲内において、1日内において単回で、又は数回に分けて行ってもよい。投与期間も任意である。 The dose of the inhalant is appropriately set according to the administration method and the age, weight and symptoms of the patient who is the subject of the inhaler, and is not constant. Further, the administration may be performed once or divided into several times within one day within a desired dose range. The administration period is also arbitrary.
食品としては、健康食品、病者用食品、特定保健用食品、栄養補助食品等が挙げられ、特に限定はないが、本発明の効果をより高める観点から、式(I)で表される化合物が口中に比較的長い時間留まり口腔粘膜を経由して吸入される形態のものや、口に入れる前に式(I)で表される化合物が揮散して鼻腔粘膜を経由して吸入される形態のものが好ましい。具体的には、ガム、茶、飲料、飴、タブレット、ゼリー、グミ等が挙げられる。前記食品は、式(I)で表される化合物を含有する限り、従来の食品に使用されている公知の基剤、担体、添加剤等の他の成分を含有することができ、適宜、常法により製造することができる。 Examples of the food include health foods, foods for the sick, foods for specified health use, dietary supplements and the like, and are not particularly limited. From the viewpoint of further enhancing the effects of the present invention, the compound represented by the formula (I) That remains in the mouth for a relatively long time and is inhaled through the oral mucosa, or in which the compound represented by formula (I) evaporates and is inhaled through the nasal mucosa before entering the mouth Are preferred. Specifically, gums, teas, beverages, rice cakes, tablets, jelly, gummi and the like can be mentioned. As long as the food contains the compound represented by the formula (I), the food can contain other components such as known bases, carriers and additives used in conventional foods. It can be manufactured by the method.
木工加工品としては、式(I)で表される化合物を含有する溶液を木工製品に塗工、含浸する等によって得られる形態のものが挙げられ、通常、該化合物を自然蒸散させることにより使用される。 Examples of woodwork products include those obtained by coating, impregnating, etc., a solution containing the compound represented by formula (I) onto a woodworking product, and usually used by spontaneously evaporating the compound. Is done.
以下、実施例を示して本発明を具体的に説明するが、本発明は下記実施例に制限されるものではない。 EXAMPLES Hereinafter, although an Example is shown and this invention is demonstrated concretely, this invention is not restrict | limited to the following Example.
[化合物の合成例1](ジブチルマレイン酸)
無水マレイン酸5g(0.043mol)を無水ベンゼン100mLに溶解した後、1−ブタノール9.56g(0.129mol)を加え、さらに、酸触媒としてスルファミン酸(NH2SO3H)0.97g(0.01mol)を添加して、加熱還流(90〜110℃)を2時間行なった。その後、減圧下にてベンゼンを留去し、酢酸エチルで抽出することにより、ジブチルマレイン酸を得た(収率62%)。なお、市販品を用いる場合には、東京化成工業社製を使用することができる。
[Compound Synthesis Example 1] (Dibutylmaleic acid)
After dissolving 5 g (0.043 mol) of maleic anhydride in 100 mL of anhydrous benzene, 9.56 g (0.129 mol) of 1-butanol was added, and 0.97 g of sulfamic acid (NH 2 SO 3 H) was further added as an acid catalyst. 0.01 mol) was added and heating to reflux (90-110 ° C.) was carried out for 2 hours. Thereafter, benzene was distilled off under reduced pressure and extracted with ethyl acetate to obtain dibutylmaleic acid (yield 62%). In addition, when using a commercial item, the Tokyo Chemical Industry Co., Ltd. product can be used.
[化合物の合成例2](ジオクチルマレイン酸)
無水マレイン酸5g(0.043mol)を無水ベンゼン200mLに溶解した後、1−オクタノール16.80g(0.129mol)を加え、さらに、酸触媒としてスルファミン酸(NH2SO3H)1.46g(0.015mol)を添加して、加熱還流(90〜110℃)を4時間行なった。その後、減圧下にてベンゼンを留去し、酢酸エチルで抽出することにより、ジオクチルマレイン酸を得た(収率44%)。なお、市販品を用いる場合には、東京化成工業社製を使用することができる。
[Synthesis Example 2 of Compound] (Dioctylmaleic acid)
After dissolving 5 g (0.043 mol) of maleic anhydride in 200 mL of anhydrous benzene, 16.80 g (0.129 mol) of 1-octanol was added, and further 1.46 g of sulfamic acid (NH 2 SO 3 H) as an acid catalyst ( 0.015 mol) was added and heating to reflux (90-110 ° C.) was carried out for 4 hours. Thereafter, benzene was distilled off under reduced pressure, followed by extraction with ethyl acetate to obtain dioctylmaleic acid (yield 44%). In addition, when using a commercial item, the Tokyo Chemical Industry Co., Ltd. product can be used.
[化合物の合成例3]〔ビス(2−エチルヘキシル)マレイン酸〕
無水マレイン酸5g(0.043mol)に2−エチル−1−ヘキサノール16.80g(0.129mol)を加え、さらに、酸触媒としてp−トルエンスルホン酸無水物1.72g(0.01mol)を添加した後、130〜140℃で3時間加熱し、酢酸エチルで抽出することにより、ビス(2−エチルヘキシル)マレイン酸を得た(収率38%)。なお、市販品を用いる場合には、東京化成工業社製を使用することができる。
[Compound Synthesis Example 3] [Bis (2-ethylhexyl) maleic acid]
16.80 g (0.129 mol) of 2-ethyl-1-hexanol was added to 5 g (0.043 mol) of maleic anhydride, and 1.72 g (0.01 mol) of p-toluenesulfonic anhydride was added as an acid catalyst. After that, the mixture was heated at 130 to 140 ° C. for 3 hours and extracted with ethyl acetate to obtain bis (2-ethylhexyl) maleic acid (yield 38%). In addition, when using a commercial item, the Tokyo Chemical Industry Co., Ltd. product can be used.
[化合物の合成例4]〔ビス(2−エチルヘキシル)フタル酸〕
無水フタル酸5g(0.030mol)に2−エチル−1−ヘキサノール11.72g(0.090mol)を加え、さらに、酸触媒としてp−トルエンスルホン酸無水物1.72g(0.01mol)を添加した後、130〜140℃で4時間加熱し、酢酸エチルで抽出することにより、ビス(2−エチルヘキシル)フタル酸を得た(収率34%)。なお、市販品を用いる場合には、シグマ−アルドリッチ社製を使用することができる。
[Compound Synthesis Example 4] [Bis (2-ethylhexyl) phthalic acid]
11.72 g (0.090 mol) of 2-ethyl-1-hexanol was added to 5 g (0.030 mol) of phthalic anhydride, and 1.72 g (0.01 mol) of p-toluenesulfonic anhydride was added as an acid catalyst. Then, the mixture was heated at 130 to 140 ° C. for 4 hours and extracted with ethyl acetate to obtain bis (2-ethylhexyl) phthalic acid (yield 34%). In addition, when using a commercial item, the Sigma-Aldrich company make can be used.
[試料溶液の調製]
以下の試料2.5gをジプロピレングリコール(和光純薬工業社製)に溶解して各試料溶液を50mLに調製した〔5%(w/v)濃度〕。なお、Sample1〜3、5は上記で合成したものを、Sample4はシグマ-アルドリッチ社製を使用した。
Sample1:ジブチルマレイン酸
Sample2:ジオクチルマレイン酸
Sample3:ビス(2−エチルヘキシル)マレイン酸
Sample4:1,4−ビス(2−エチルヘキシル)ベンゼン
Sample5:ビス(2−エチルヘキシル)フタル酸
[Preparation of sample solution]
2.5 g of the following samples were dissolved in dipropylene glycol (manufactured by Wako Pure Chemical Industries, Ltd.) to prepare each sample solution to 50 mL [5% (w / v) concentration]. Samples 1 to 3 and 5 were synthesized as described above, and Sample 4 was manufactured by Sigma-Aldrich.
Sample 1: Dibutyl maleate Sample 2: Dioctyl maleate Sample 3: Bis (2-ethylhexyl) maleate Sample 4: 1,4-bis (2-ethylhexyl) benzene Sample 5: Bis (2-ethylhexyl) phthalic acid
[試験動物]
8週齢の雄性、ddy系マウス(九動株式会社製)を用意し、約1週間の馴化期間を経た後、体重を基準にSample1〜4については各群7匹とし、Sample5については1群10匹として用いた。なお、Controlとしては、Sample1〜4に対するControl群(7匹)とSample5に対するControl群(10匹)をそれぞれ用意した。
[Test animal]
After preparing an 8-week-old male, ddy mouse (manufactured by Kudo Co., Ltd.) and passing through an acclimatization period of about 1 week, 7 samples were assigned to each of Samples 1 to 4 based on body weight. Ten animals were used. In addition, as the Control, a Control group (7 animals) for Samples 1 to 4 and a Control group (10 animals) for Sample 5 were prepared.
[暴露試験]
上記で調製した試料溶液500μLを、におい紙(66.4cm2の濾紙)に含浸させて試料含有におい紙を調製後、マウス用メタボリックケージの蓋の裏側に前記におい紙を取り付けた。そこにマウスを1匹ずつ入れ、飼育室(22℃、RH50%)の一定の場所にて、におい紙の発する臭気をマウスに自然吸入(暴露)させ、24時間に排出する糞の個数、糞の総重量及び体重を計測した。また、得られた糞については、乾燥(138℃、2時間)させて乾燥重量を測定し、糞中に含まれる水分量及び水分含量を算出した。試験は5日間連続して暴露を行い、毎朝9〜10時の間に計測、及び新しい試料含有におい紙の取り付けを行った。なお、Control群には、ジプロピレングリコール500μLを含浸させたにおい紙を取り付けて、同様に試験を行った。
[Exposure test]
After scent paper (66.4 cm 2 filter paper) was impregnated with 500 μL of the sample solution prepared above to prepare a sample-containing scent paper, the scent paper was attached to the back of the lid of the mouse metabolic cage. Place one mouse at a time, let the mouse naturally inhale (expose) the smell of odor paper in a certain place in the breeding room (22 ° C, RH 50%), and the number of feces excreted in 24 hours, feces The total weight and body weight were measured. Moreover, about the obtained feces, it dried (138 degreeC, 2 hours), the dry weight was measured, and the moisture content and water content contained in feces were computed. In the test, exposure was continuously performed for 5 days, and measurement was performed every morning from 9 to 10 o'clock, and a new sample-containing odor paper was attached. In addition, the odor paper impregnated with 500 microliters of dipropylene glycol was attached to the Control group, and the test was done similarly.
[データ処理]
各項目のデータは、各マウスの5日間の合計値をSample1〜4については7匹について平均したものを、Sample5については10匹について平均したものを用いた。結果を表1及び2に示す。
[Data processing]
As the data for each item, the average value of 7 mice for Samples 1 to 4 and the average of 10 mice for Sample 5 were used for the total value of each mouse for 5 days. The results are shown in Tables 1 and 2.
また、Sample群とControl群との比較は、糞の総重量、乾燥重量、水分量、水分含量及び個数について、ノンパラメトリック分析のMann−WhitneyのU検定により有意差検定を行った。結果を表3及び4に示す。 In addition, for comparison between the Sample group and the Control group, a significant difference test was performed by the Mann-Whitney U test of nonparametric analysis for the total weight, dry weight, water content, water content and number of feces. The results are shown in Tables 3 and 4.
以上の結果より、Sample1〜5は、Controlに比べて排便促進効果があることが分かる。なかでも、Sample1、3、4に含有される化合物、即ち、ジブチルマレイン酸、ビス(2−エチルヘキシル)マレイン酸、1,4−ビス(2−エチルヘキシル)ベンゼンは、より優れた排便促進作用を有することが示唆される。 From the above results, it can be seen that Samples 1 to 5 have a defecation promoting effect compared to Control. Among them, the compounds contained in Samples 1, 3, and 4, ie, dibutylmaleic acid, bis (2-ethylhexyl) maleic acid, and 1,4-bis (2-ethylhexyl) benzene have a superior defecation promoting action. It is suggested.
本発明の排便促進用組成物は、便秘の予防、改善、治療等において好適に用いられるものである。 The composition for promoting defecation of the present invention is suitably used for prevention, improvement, treatment, etc. of constipation.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008330423A JP5426156B2 (en) | 2008-12-25 | 2008-12-25 | Defecation promoting composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008330423A JP5426156B2 (en) | 2008-12-25 | 2008-12-25 | Defecation promoting composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010150188A JP2010150188A (en) | 2010-07-08 |
JP5426156B2 true JP5426156B2 (en) | 2014-02-26 |
Family
ID=42569690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008330423A Active JP5426156B2 (en) | 2008-12-25 | 2008-12-25 | Defecation promoting composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5426156B2 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001080893A1 (en) * | 2000-04-26 | 2001-11-01 | Eisai Co., Ltd. | Medicinal compositions promoting bowel movement |
-
2008
- 2008-12-25 JP JP2008330423A patent/JP5426156B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2010150188A (en) | 2010-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110353298A (en) | Electronic cigarette liquid | |
JP2010001282A (en) | Isothiocyanate-containing composition, food, foodstuff, medicine, cosmetic, daily necessary and miscellaneous good | |
JP2009173585A (en) | Tranquilizing effect-imparting agent, tranquilizing perfume composition, and cosmetic and food and drink having tranquilizing effect | |
Khalid et al. | GC-MS analysis and cytotoxicity evaluation of shammah (smokeless tobacco) samples of Jazan region of Saudi Arabia as promoter of cancer cell proliferation | |
WO2010084661A1 (en) | Composition, food, food material, pharmaceutical preparation, cosmetic and commodity each containing isothiocyanate compound | |
JP5426156B2 (en) | Defecation promoting composition | |
JP2020040884A (en) | Anti-fatigue composition by activation of energy metabolism in muscle cell containing artichoke leaf extract or cynaropicrin | |
Owston et al. | A 90-day toxicity study of phenylethyl alcohol in the rat | |
JP5851398B2 (en) | Sympathetic nerve inhibitor | |
JP5781573B2 (en) | Method for producing cigarette using onamomi leaf extract | |
JP3656972B2 (en) | Alcohol smell reducing agent | |
JP2013144665A (en) | Oral body odor-improving composition | |
JP2016094378A (en) | Composition for suppressing mouth odors containing myrsine seguinii h. lev. extract | |
JP5992304B2 (en) | Oral body odor improving composition | |
JP2009280573A (en) | Body odor inhibitor for internal use | |
JP5992307B2 (en) | Composition for improving oral odor | |
JPS62265236A (en) | Stomachic composition | |
US20230263189A1 (en) | Additive for animals that contain saponins, phenolic compounds and p-cimenol, and procedure for its obtention | |
JP2018104383A (en) | TRPV4 activity inhibitor | |
JPH02184683A (en) | Consciousness level depressor | |
JP5992309B2 (en) | Composition for improving oral odor | |
JP6251848B1 (en) | Dynapenia inhibitor | |
KR20220152560A (en) | Formulations, compositions and various uses containing caryophyllene | |
TW202320740A (en) | Composition for inhibiting neuron degeneration | |
Hartwig et al. | Isodecyl oleate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110803 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20110803 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130702 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130830 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131111 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131128 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5426156 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |